However, it is postulated, that decreased survival in cervical cancer is associated with the domination of Treg FoxP3+ lymphocytes over CD103+ lymphocytes, while the latter are a good biomarker for HPV-targeted immunotherapy [87, 88]. The gene discussed is ITGAE; the disease is cervical carcinoma.